Increased Neutrophil-Endothelial Adhesion Induced by Placental Factors Is Medicated by Platelet-Activating Factor in Preeclampsia

Abstract

Objective: Endothelial cell activation or dysfunction and neutrophil-endothelial cell adhesion have been suggested to be important in the pathophysiology of preeclampsia. However, the mechanisms that underlie the alteration of endothelial cell function in preeclampsia are unknown. Placenta from preeclamptic pregnancies produces mediators and autacoids, which may be released into the maternal circulation and modulate endothelial function. In this study, the effect of placental factor(s) on neutrophil-endothelial adhesion and the possible role of platelet-activating factor (PAF) in mediating the response have been examined.

Methods: Endothelial cells were isolated from human umbilical veins (HUVECs) from normal pregnancies. Confluent primary passage HUVECs were exposed to conditioned medium derived from normal and preeclamptic placental tissue cultures, with unconditioned medium as a control. Placental-conditioned medium was prepared by incubation of placental whole viollous tissue in Dulbecco's Modified Eagle's Medium (DMEM) for 48 hours. Neutrophil-endothelial adhesion assays were performed to evaluate placental factors in mediating neutrophil-endothelial adhesion, and a PAF-³H scintillation proximity assay (SPA) system was used to determine endothelial PAF production. The PAF-receptor antagonist WEB 2086 was used to block placental factor-mediated increased neutrophil-endothelial adhesion induced by conditioned medium derived from preeclamptic placenta.

Results: Neutrophils were significantly more adherent to HUVECs treated with conditioned medium from preeclamptic placentas (28.44 ± 2.47%) than to HUVECs treated with conditioned medium from normal placentas (18.95 ± 1.57%) or with unconditioned medium (14.60 ± 1.29%, P < .01). Also, HUVECs exposed to preeclamptic placental-conditioned medium produced more PAF than the cells exposed to normal conditioned medium and unconditioned medium, 416.18 ± 17.14 pg/1 × 10⁷ cells versus 330.90 ± 35.70 and 296.43 ± 44.40 pg/1 × 10⁷ cells, P < .05, respectively. The PAF receptor antagonist WEB 2086 completely blocked increased neutrophil-endothelial adhesion induced by preeclamptic placental-conditioned medium (13.24 ± 0.81% versus 31.31 ± 4.75%, P < .01).

Conclusion: In preeclampsia, the placenta releases one or more factors promoting neutrophil-endothelial adhesion. the increased neutrophil-endothelial adhesion thereby induced is a PAF-mediated event. It is suggested that if preeclamptic placentas release toxic factors into the maternal circulation in vivo, these factors may contribute to the altered vascular endothelial cell function in preeclampsia.

Keywords

Endothelial cells placenta neutrophil-endothelial adhesion platelet-activating factor preeclampsia

Get full access to this article

View all access options for this article.

References

1. Roberts JM , Redman CWG . Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 1993;341:1447-1451.

2. Roberts JM , Taylor RN , Musci TJ , Rodgers GM , Hubel CA , McLaughlin MK . Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989;161:1200-1204.

3. Rodgers GM , Taylor RN , Roberts JM . Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988;159:908-914.

4. Giugliano D , Ceriello A , Paolisso G . Oxidative stress and diabetic vascular complications. Diabetes Care 1996;19:257-267.

5. Wang Y , Adair CD , Coe L , Weeks JW , Lewis DF , Alexander JS . Activation of endothelial cells in preeclampsia: Increased neutrophil-endothelial adhesion correlates with up-regulation of adhesion molecule P-selectin in human umbilical vein endothelial cells isolated from preeclampsia. J Soc Gynecol Invest 1998;5:237-243.

6. Walsh SW . Preeclampsia: An imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985;152:335-340.

7. Wang Y , Walsh SW , Kay HH . Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol 1992;167:946-949.

8. Wang Y , Walsh SW , Guo J , Zhang J . The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 1991;165:1695-1700.

9. Smarason AK , Sargent IL , Redman CWG . Endothelial cell proliferation is suppressed by plasma but not serum from women with preeclampsia. Am J Obstet Gynecol 1996;174:787-793.

10.

10. Imaizumi T-A , Stafforini DM , Yamada Y , McIntyre TM , Prescott SM , Zimmerman GA . Platelet-activating factor: A mediator for clinicians. J Intern Med 1995;238:5-20.

11.

11. McIntyre TM , Zimmerman GA , Satoh K , Prescott SM . Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest 1985;76:271-280.

12.

12. Camussi G , Aglietta M , Malavasi F , et al. The release of platelet-activating factor from human endothelial cells in culture. J Immunol 1983;131:2397-2403.

13.

13. Garcia JGN , Azghani A , Callahan KS , Johnson AR . Effect of platelet activating factor on leukocyte-endothelial cell interactions. Thromb Res 1988;51:83-96.

14.

14. Walsh SW , Wang Y , Jesse R . Placental production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. Hypertens Pregn 1996;15:101-111.

15.

15. Jaffe EA , Nachman RL , Becker CG , Minick CR . Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-2756.

16.

16. Market M , Andrews PC , Babior BM . Measurement of O2 production by human neutrophils. The preparation and assay of NADPH oxidase-containing particles from human neutrophils. Methods Enzymol 1984;105:358-365.

17.

17. Ohno N , Ichikawa H , Coe L , Kvietys PR , Granger DN , Alexander JS . Soluble selections and ICAM-1 modulate neutrophilendothelial adhesion and diapedesis in vitro. Inflammation 1997;21:313-324.

18.

18. Ichikawa H , Wolf RE , Aw TY , et al. Exogenous xanthine promotes neutrophil adherence to cultured endothelial cells. Am J Physiol 1997;273:G342-G347.

19.

19. Bligh EG , Dyer WJ . A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.

20.

20. Redman CWG . Current topic: Pre-eclampsia and the placenta. Placenta 1991;12:301-308.

21.

21. Smarason AK , Sargent IL , Starkey PM , Redman WG . The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol 1993;100:943-949.

22.

22. Walsh SW , Wang Y . Secretion of lipid peroxides by the human placenta. Am J Obstet Gynecol 1993;169:1462-1466.

23.

23. Braquet P , Hosford D , Braquet M , Bourgain R , Bussolino F . Role of cytokines and platelet-activating factor in microvascular immune injury. Inat Arch Allergy Immunol 1989;88:88-100.

24.

24. Lewis MS , Whatley RE , Cain P , McIntyre TM , Prescott SM , Zimmerman GA . Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest 1988;82:2045-2055.

25.

25. Ohshige A , Yoshimura T , Matsui K , Koyama H , Io M , Okamura H . Reduced platelet-activating factor-acetylhydrolase activity in maternal plasma obtained from normotensive pregant women destined to develop pregnancy-induced hypertension. Hypertens Pregn 1998;17:297-306.

26.

26. Coughlan AF , Hau H , Dunlop LC , Berndt MC , Hancock WW . P-Selection and platelet-activating factor mediate initial endotoxin-induced neutropenia. J Exp Med 1994;179:329-334.